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Henry Gewirtz, MDI n this issue of iJACC, Nesterov et al. (1) report ona multicenter clinical trial (RUBY-10) designedto determine the extent to which 10 different
“software packages” (SPs) agreed in measurements of
absolute values of rest and adenosine stress myo-
cardial blood ﬂow (MBF) and ﬂow reserve (MFR). The
SPs were applied to a common set of positron emission
tomography (PET) rubidium 82 (82Rb) data. Each of
10 sites used its own SP for MBF determinations. PET
data were acquired at University Hospital, Lausanne,
which performed image reconstruction. The study
population consisted of 48 patients with known
(w50%) or suspected coronary artery disease.SEE PAGE 1119Output of the SPs agreed “if they simultaneously
had an intraclass correlation coefﬁcient (ICC) >0.75
and a difference <20% of the median across all pro-
grams.” The number of pairwise and other relevant
comparisons is enormous, and the authors are to be
commended for development of Figures 1 and 2,
which provided an excellent visual representation of
a very complex data analysis (1). Although it is readily
apparent from Figure 1 that wide differences both in
rest and stress MBF (and hence MFR) resulted from
different SPs applied to the same dataset, the authors
focus on Figure 2 which shows results from 8 SPs
that used a single-tissue compartment tracer model
(1-TCM) (Lortie et al. [2]). The results from 1 SP
(retention model of Yoshida et al. [3]) were judged
outliers, and those of the other 7 satisﬁed the pre-
speciﬁed conditions for agreement. Accordingly, the
authors conclude any of the 7 SP implementations of
the 1-TCM may be used “interchangeably to process
data acquired with a common imaging protocol.”*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
of the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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the Wild Family Foundation.Another goal was to “analyze the current situation
in 82Rb PET quantiﬁcation to help establish common
and robust methods to support collaborative multi-
center clinical trials.” Such trials, of course, would
send PET data to a core laboratory for processing and
analysis. The present study, although exploratory,
did exactly the opposite. Given the differing
modeling approaches that each “black box” used for
determining crucial factors such as arterial input
function, spill over, and partial volume corrections
and dependence of 82Rb myocardial uptake on MBF, it
is unsurprising that MBF values differed, in some
comparisons considerably. Thus, the reader may ask:
1) how great a difference between SP results is
acceptable; and 2) if SP output differs, which (if either
or among many) is correct?
The authors address the ﬁrst question by noting that
test-retest reproducibility is 20% (4). However,
Efseaff et al. (4) considered only rest MBF and tested
multiple methods for image reconstruction, each of
which provided different values of MBF and repro-
ducibility. Ultimately, an OSEM method was used and
rest MBF data normalized to rate-pressure product
(not done in the present study) to obtain the 20%
result. Whether the OSEM parameters and other
methods used to acquire and reconstruct the images at
Lausanne (1) were exactly the same as those used in
Ottawa (4) is not stated but obviously matters. Then,
too, there is the physiology and what acceptance of
20%means regarding both rest but more importantly
stress MBF. Figure 2 (present study [1]) shows for each
major coronary vascular territory the green zone
(20%) for stress MBF encompasses 0.40 ml/min/g
and similar spread for MFR (unit less). Further, any
given SP may have data points on both sides of the
zero difference point. Thus, the full range of observed
variation for a given program was as much 0.8
ml/min/g for stress MBF and MFR. Given that an
ischemia threshold of just 0.91 ml/min/g has been
demonstrated for 82Rb PET and dipyridamole stress
(5,6), “agreement” among SPs that may vary by nearly
50% of that level is unacceptably high and carries the
risk of misclassifying a great many patients.
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1129The authors address the second question by
acknowledging the most important limitation of their
study—the absence of a gold standard by which to
judge the accuracy of each SP. It is entirely possible
that one of the outlier SPs was most accurate. Thus,
the tissue retention model of Yoshida et al. (3),
incorporated in a version employed by the Cardio-
vascular Imaging Technologies (CVIT) group and
in part in the 1-TCM model of El Fakhri et al. (7),
was found to differ notably (CVIT group greater than
that of El Fakhri et al. [7]) from the 7 SPs using some
version of Lortie 1-TCM (2). The retention model of
Lautamaki et al. (8) that was used by the Munich
group was virtually identical to that of Yoshida et al.
(3) and also was an outlier. Although all 3 models
have objective data to support them, the study of
Lortie et al. (2) was validated in human subjects
with 13N-ammonia as the gold standard. In contrast,
Yoshida et al. (3) and Lautamaki et al. (8) both made
direct measurements in closed chest canine models
either by comparing PET 82Rb coronary ﬂow reserve
with that of coronary ﬂow reserve by electromagnetic
ﬂow meter (3) or with microspheres values of MBF
(8). Accordingly, the retention models may provide
more accurate measurements of absolute MBF than
that of 1-TCM. The Yoshida et al. (3) model also is the
only one for which quantitative measurements of
absolute MBF with PET 82Rb and dipyridamole stress
and objective indicators of ischemia (not percent of
stenosis or fractional ﬂow reserve) has been used to
deﬁne a level of MBF (0.91 ml/min/g) below which
actual ischemia is likely to occur (5,6). Thus, the
importance of getting the absolute value of stress
MBF correct is underscored not only by the data ofJohnson and Gould (5,6) but also by the fact that
the level of the ischemic threshold for exercise
stress likely is higher, because 40% of those with
“deﬁnite ischemia” reported by Johnson and Gould
exhibited coronary steal with dipyridamole (5), and
data from several experiments in which increased
myocardial oxygen demand is involved indicate the
ischemia threshold more likely is in the range of 2 to
3 ml/min/g (9–11).
Accordingly, take-away points for those using PET
82Rb for quantitative measurements of absolute MBF
are as follows. First, caveat emptor, the SP used to
obtain absolute MBF matters and 20% especially
for the stress study translates into differences in
absolute MBF that are too large to accept as “inter-
changeable.” A core laboratory for a clinical trial
naturally would use only 1 SP, but readers will want
to know which one, an important contribution of the
paper.
Second, which SP(s) provides accurate absolute
values of MBF obviously matters. Although 1-TCM’s
and retention models have validation data, animal
experiments (3,8) associated with retention SPs are
more robust and may be more accurate. In any case,
absolute values of MBF obtained with reported SPs
(including that of 1-TCM) are neither necessarily
equivalent nor “interchangeable” from a physiolog-
ical standpoint, another very valuable contribution of
the current paper.
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